Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aura Biosciences Inc | AURA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 7.36 | 06:00:12 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 7.36 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 5.99 - 13.50 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 7.36 | USD |
Aura Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 281.59M | 38.26M | - | 0 | -76.41M | -2.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aura Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AURA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.29 | 7.84 | 6.9625 | 7.44 | 373,683 | 0.07 | 0.96% |
| 1 Month | 7.97 | 8.07 | 6.64 | 7.35 | 194,752 | -0.61 | -7.65% |
| 3 Months | 8.38 | 8.74 | 6.64 | 7.44 | 204,064 | -1.02 | -12.17% |
| 6 Months | 8.20 | 9.72 | 6.64 | 7.95 | 176,480 | -0.84 | -10.24% |
| 1 Year | 11.99 | 13.50 | 5.99 | 8.49 | 148,937 | -4.63 | -38.62% |
| 3 Years | 14.10 | 26.16 | 5.99 | 11.24 | 114,015 | -6.74 | -47.80% |
| 5 Years | 14.10 | 26.16 | 5.99 | 11.24 | 114,015 | -6.74 | -47.80% |
Aura Biosciences Description
| Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. |
